EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib By Ogkologos - May 22, 2026 323 0 Facebook Twitter Google+ Pinterest WhatsApp Palbociclib Viatris is a generic of Ibrance which has been authorised in the EU since 2016 Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Cómo solicitar Medicare cuando tiene cáncer December 12, 2023 Our COVID-19 Response: How GreaterGood Is Making An Impact During The... April 23, 2020 Study Identifies Hundreds of Potential Targets for Cancer Drugs September 11, 2024 Can Acupuncture Help Cancer Survivors with Chronic Pain? April 22, 2021 Load more HOT NEWS For Children with Retinoblastoma, Disparities Seen across the Globe It Might Sound Trite But… FDA Grants Regular Approval to fam-Trastuzumab Deruxtecan-nxki for Unresectable or Metastatic... How Does Ovarian Cancer Form? A New Study Points to MicroRNA
